More Canadian Institutions and Asset Managers Using ETFs in

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
88
More Canadian Institutions and Asset Managers Using ETFs in Fixed Income, Smart Beta Strategies: Greenwich Report

TORONTO, ONTARIO--(Marketwired - March 9, 2017) - Canadian institutional investors, who have led the world in their innovative applications of exchange traded funds to realize their investment strategies, are increasingly turning to ETFs not just for equity allocations, but also for smart beta and fixed income strategies, according to a recent Greenwich Associates study.

In its fourth annual study of institutional ETF use, sponsored by BlackRock Asset Management Limited (BlackRock Canada), Greenwich Associates found that the increasing innovation in ETF adoption is building on Canadian institutions' strong reliance on ETFs. Participating institutional investors - including asset managers, institutional funds and insurance-related firms - hold an average of 16 per cent of total assets under management in ETFs, and more than a quarter of respondents planned to increase their ETF holdings in the next 12 months.

One driver of growth in institutional adoption has been the increasing use of ETFs as an important means to express strategy, as opposed to tactics. In fact, more than half - 58 per cent - of institutions characterize their ETF holdings as strategic in nature, and nearly two-thirds (63 per cent) hold their ETF investments for a year or longer, the threshold normally considered a "strategic" investment.

"Institutional investors' use of ETFs has grown in absolute terms in recent years, but this survey shows that it has also grown in diversity and sophistication," said Warren Collier, Head of Canada iShares for BlackRock Canada. "The Canadian industry started using the funds largely for tactical applications, but since then we've seen strategic applications grow to the point where strategy now trumps tactics when it comes to ETF use. And where it gets really interesting is how sophisticated those applications have become."

Click here to access the full report.

Seizing ETFs' diversity advantage

According to the Greenwich Associates study, the benefits of ETFs for institutional investors are varied and broad. Almost 85 per cent cite ease of use as a primary reason for investing in equity ETFs, while 80 per cent say they invested in ETFs because of the speed with which they can execute trades to gain diversified exposures. More than three-quarters cite liquidity, and more than two-thirds cite market access, low trading costs and/or attractive management fees, as primary reasons for using ETFs.

Institutional investors are realizing those benefits across a wide range of applications, both strategic and tactical. Two of the top three institutional uses of ETFs - international diversification, cited by 71 per cent of respondents, and core allocation, cited by 55 per cent - are strategic in nature. Institutions are, of course, continuing to use the funds for tactical applications, including portfolio adjustments (68 per cent), rebalancing (47 per cent), transition management (34 per cent) and interim beta (21 per cent). But they have also made ETFs increasingly important components in critical portfolio functions. Nearly half are using the funds in their liquidity management strategies, and two in five employ ETFs as part of risk management/overlay strategies.

Liquidity needs drive growth in Fixed Income ETFs

Given ETFs' origins as equity funds, it is perhaps not surprising that Canadian institutional use is most mature in equities. Nearly all of the respondents in the Greenwich Associates study invest in equity ETFs: Close to two-thirds invest in U.S. and international funds, and more than half invest in domestic ETFs. Yet they are also taking advantage of the diversity of asset classes today's ETF marketplace offers. For instance, more than 15 per cent of ETF investors use them to gain exposure to commodities, and close to 20 per cent employ them for access to real estate income trusts (REITs).

Nowhere is the adoption of non-equity ETFs more apparent than in fixed income. According to Greenwich Associates, close to two-thirds of institutional users invest in bond funds, including more than three-quarters of asset managers and insurance companies.

Canadian institutions continue to rely on fixed-income ETFs much more heavily than their counterparts in other countries. On average, Canadian institutional ETF users invest about a quarter (26 per cent) of total fixed-income assets in bond ETFs - more than three times the average allocation among counterpart European institutions, for example. One reason lies in the particularly large allocations by insurance companies, some of which hold 35 per cent of FI assets in ETFs.

Why are institutions turning to bond ETFs? The reasons vary, from ease-of-use and single-trade diversification (cited by 71 per cent of respondents) to low management fees (67 per cent) and trading costs compared to cash bonds (52 per cent). The prime motivator for using fixed-income ETFs, however, is liquidity, cited by more than 80 per cent of respondents.

According to Greenwich Associates, Canadian institutions have not experienced fixed income liquidity constraints to the same extent as their European and U.S. counterparts have, but the global landscape is clearly shifting in response to new, post-crisis bank capital requirements. Despite their already high level of bond ETF use, continuing concerns over liquidity could well drive even further adoption by Canadian institutions - many of which have been exposed to liquidity constraints when investing in international fixed income.

The Smart Beta solution

In the continuing low-rate environment, Canadian institutions have had to look beyond traditional securities for returns, and many are turning to smart beta ETFs as part of the solution. Nearly a third (31 per cent) of surveyed institutions invest in these funds - a level of smart beta use that continues to be higher Europe and just below the U.S. Furthermore, more than half of smart beta ETF users plan to increase their allocations to these funds in the next year.

The mix of Canadian institutional use of smart betas is evolving. As in last year's survey, multi-factor ETFs continue to be popular, used by half of smart beta ETF investors. Notably, however, half of smart beta investors - more than those who reported using minimum-volatility funds, which dominated institutional use last year - hold dividend/equity-income ETFs. That, according to Greenwich Associates, is a remarkable development - and a sign of institutions' need for new income sources - given that no investors in last year's survey were using dividend ETFs at all.

"The results of this year's Greenwich Associates study reflect the major trends that we see in our work with institutional investors on the ground," said iShares Canada's Collier. "On the one hand, institutions are becoming more familiar with the ever-growing range of ETF solutions available to them. On the other, institutional investors are continually finding new and sophisticated ways to apply those solutions, both in response to market forces and to express their strategic views. In an ever-changing investment environment, we expect those trends to continue going forward."

Methodology

For its current Canadian ETF Study, Greenwich Associates interviewed 53 institutional investors, including 25 asset managers, 24 institutional funds and four insurance companies. The cohort of institutional funds, which includes public pension funds, corporate defined benefit pension funds and endowments/foundations, is the biggest sample size to date for the annual study. Most of the study participants are large institutional investors: 38 per cent have assets under management of more than $5 billion, 18 per cent manage more than $20 billion, and eight per cent manage more than $100 billion.

About BlackRock

BlackRock is a global leader in investment management, risk management and advisory services for institutional and retail clients. At December 31, 2016, BlackRock's AUM was US$5.1 trillion. BlackRock helps clients around the world meet their goals and overcome challenges with a range of products that include separate accounts, mutual funds, iShares ® (exchange-traded funds), and other pooled investment vehicles. BlackRock also offers risk management, advisory and enterprise investment system services to a broad base of institutional investors through BlackRock Solutions ® . As of December 31, 2016, the firm had approximately 13,000 employees in more than 30 countries and a major presence in global markets, including North and South America, Europe, Asia, Australia and the Middle East and Africa. For additional information, please visit the Company's website at www.blackrock.com/ca / Twitter: @BlackRockCA / Blog: www.blackrockblog.com/can

About iShares

iShares ® is a global leader in exchange-traded funds (ETFs), with more than a decade of expertise and commitment to individual and institutional investors of all sizes. With over 700 funds globally across multiple asset classes and strategies and more than US$1 trillion in assets under management as of December 31, 2016, iShares helps clients around the world build the core of their portfolios, meet specific investment goals and implement market views. iShares funds are powered by the expert portfolio and risk management of BlackRock, trusted to manage more money than any other investment firm 1 .

1 Based on US$5.147 trillion in AUM as of 12/31/16

This material represents an assessment of the market environment as of the date indicated; is subject to change; and is not intended to be a forecast of future events or a guarantee of future results. This information should not be relied upon by the reader as research or investment advice regarding the funds or any issuer or security in particular.

iShares® ETFs are managed by BlackRock Asset Management Canada Limited. Commissions, trailing commissions, management fees and expenses all may be associated with investing in iShares ETFs. Please read the relevant prospectus before investing. The funds are not guaranteed, their values change frequently and past performance may not be repeated. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional.

© 2017 BlackRock Asset Management Canada Limited. All rights reserved. iSHARES and BLACKROCK are registered trademarks of BlackRock, Inc., or its subsidiaries in the United States and elsewhere. Used with permission. iSC-2670-0317

Contact for Media: Maeve Hannigan T - 416-643-4058 C - 416-564-1540 Email: Maeve.Hannigan@blackrock.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

BioXcel Therapeutics Faces Challenges Amidst 52-Week Low

Updated Category News Views 85

BioXcel Therapeutics: Facing the Heat BioXcel Therapeutics Inc. (BTAI) is in the doghouse—its stock just hit a jaw-dropping 52-week low of $0.53. That's an eye-watering drop of over 80% in the last year. Investors are glued to their screens, weighing whether to grab some shares at rock-bottom prices or steer clear as BioXcel grapples with mounting obstacles. This sharp...

Continue Reading
Guidehouse Welcomes Ron White as New Chief Information Officer

Updated Category News Views 315

Guidehouse Appoints Ron White as Chief Information Officer Advancing the firm's AI-led strategy with visionary leadership to drive business transformation and scalable innovation MCLEAN, Va. – Guidehouse, a global AI-led professional services firm, has recently appointed Ron White as its Chief Information Officer (CIO). With over 35 years of expertise in enterprise...

Continue Reading
Natural Ingredients Driving Growth in Cosmetics Market

Updated Category News Views 186

Market Growth Driven by Consumer Demand Recent studies indicate that the chemicals market for cosmetics and toiletries is experiencing significant growth. The market is set to increase from $27.7 billion to an impressive $35 billion by the end of 2029. This momentum speaks volumes about the trends affecting consumer preferences and the investment patterns of leading...

Continue Reading
Securities Investigation Alert for Semler Scientific Investors

Updated Category News Views 118

Understanding the Semler Scientific Investigation The Rosen Law Firm is actively investigating potential securities claims for investors of Semler Scientific, Inc. (NASDAQ: SMLR). This initiative addresses concerns regarding the possibility that the company may have provided significantly misleading information about its business practices to the public. Why You Should Be...

Continue Reading
Exciting Updates from Bitget Wallet: Join Fomo Thursdays

Updated Category News Views 390

Bitget Wallet Introduces Fomo Thursdays Events Bitget Wallet, a prominent non-custodial crypto wallet, is thrilled to announce the launch of its fourth Fomo Thursdays event, brought to life in collaboration with Velo Protocol. This event focuses on broadening participation in the crypto space, featuring a staggering prize pool of 3.47 million VELO tokens and 50,000 slots...

Continue Reading